Is TRAC up or down today?
TRAC is down 2.38% today, last at 0.2787. This crypto moved -2.38% versus the prior close.
TRAC · OriginTrail
Binance reconnecting · API fallback · List page updates every 30s
TRAC (OriginTrail) is trading at 0.2787, down 2.38% on the session. Price signals are mixed — no clear one-way momentum read.
Over the past 7 days, 6 headlines skew mixed. Earnings and Guidance themes dominated coverage. Recent headlines haven't moved the price much yet (avg impact 0.00%).
Social buzz is mixed — no strong crowd signal.
Analyst firms are mostly reiterating — no strong directional shift lately.
TRAC is down 2.38% today, last at 0.2787. This crypto moved -2.38% versus the prior close.
Over the past 7 days, 6 headlines skew mixed. Earnings and Guidance themes dominated coverage. Recent headlines haven't moved the price much yet (avg impact 0.00%). Dominant story: Forget Weight Loss Drugs: Here's Another Reason to Buy Eli Lilly Stock (1 source, bearish) RSI is 96 — overbought (heated) Price above 50-day average — short-term uptrend Social (demo): 41% of recent mentions lean bullish — mixed social mood.
Analyst firms are mostly reiterating — no strong directional shift lately.
Historical price chart unavailable
Live price streams via Binance WebSocket. OHLC history loads from Binance klines in your browser (USD · BTC/USDT). If Binance is unreachable, the chart stays blank rather than showing a mismatched curve.
Google Trends data is temporarily unavailable — common on cloud hosts. Search interest is optional context only.
Based on 9,862 mentions over 30d
Forget Weight Loss Drugs: Here's Another Reason to Buy Eli Lilly Stock
UK Stock Market Forecast Today (July 29): FTSE 100 Eyes Higher Open After 0.90% Rally as Investors Track Earnings – Check Stocks to Watch Today, FTSE Major Indices & More - sundayguardianlive.com
Price to earnings forward of Table Trac, Inc. – OTC:TBTC - TradingView
Hedge funds on track for another stellar year on AI boom - Reuters
GSK raises margin outlook, plots $2.5 billion restructuring to fast-track new drugs - Reuters